GSK Investigational Site — New Brunswick, New Jersey

GSK Investigational Site is a clinical research site located in New Brunswick, New Jersey, United States 8901.

Crixeo Clinical Trials Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

GSK Investigational Site has participated in 23 clinical trials with 2 currently active.

Therapeutic areas: Pulmonary Disease, Chronic Obstructive, Nasal Polyps, Lung Cancer, Non-Small Cell.

Sponsors: GlaxoSmithKline.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for GSK Investigational Site?

GSK Investigational Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has GSK Investigational Site conducted?

GSK Investigational Site has 23 clinical trials on record, with 2 currently active. Their work covers Pulmonary Disease, Chronic Obstructive, Nasal Polyps, Lung Cancer, Non-Small Cell.

Is GSK Investigational Site accredited by Crixeo Clinical Trials?

GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about GSK Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.